Evidence for cellular protein covalent binding derived from styrene metabolite.
Styrene is one of the most important industrial intermediates consumed in the world. Human exposure to styrene occurs mainly in the reinforced plastics industry, particularly in developing countries. Styrene has been found to be hepatotoxic and pneumotoxic in humans and animals. The biochemical mechanisms of styrene-induced toxicities remain unknown. Albumin and hemoglobin adduction derived from styrene oxide, a major reactive metabolite of styrene, has been reported in blood samples obtained from styrene-exposed workers. The objectives of the current study focused on cellular protein covalent binding of styrene metabolite and its correlation with cytotoxicity induced by styrene. We found that radioactivity was bound to cellular proteins obtained from mouse airway trees after incubation with (14)C-styrene. Microsomal incubation studies showed that the observed protein covalent binding required the metabolic activation of styrene. The observed radioactivity binding in protein samples obtained from the cultured airways and microsomal incubations was significantly suppressed by co-incubation with disulfiram, a CYP2E1 inhibitor, although disulfiram apparently did not show a protective effect against the cytotoxicity of styrene. A 2-fold increase in radioactivity bound to cellular proteins was detected in cells stably transfected with CYP2E1 compared to the wild-type cells after (14)C-styrene exposure. With the polyclonal antibody developed in our lab, we detected cellular protein adduction derived from styrene oxide at cysteinyl residues in cells treated with styrene. Competitive immunoblot studies confirmed the modification of cysteine residues by styrene oxide. Cell culture studies showed that the styrene-induced protein modification and cell death increased with the increasing concentration of styrene exposure. In conclusion, we detected cellular protein covalent modification by styrene oxide in microsomal incubations, cultured cells, and mouse airways after exposure to styrene and found a good correlation between styrene-induced cytotoxicity and styrene oxide-derived cellular protein adduction.
Yuan
Wei
W
Department of Medicine, University of Washington, Seattle, WA 98195, United States.
Jin
Hua
H
Chung
Jou-Ku
JK
Zheng
Jiang
J
D000818:Animals; D002460:Cell Line; D019392:Cytochrome P-450 CYP2E1 / Q000378:metabolism; D003603:Cytotoxins / Q000009:adverse effects* / Q000378:metabolism*; D004852:Epoxy Compounds / Q000009:adverse effects / Q000378:metabolism; D006801:Humans; D008297:Male; D051379:Mice; D011485:Protein Binding; D011506:Proteins / Q000378:metabolism*; D020058:Styrene / Q000009:adverse effects* / Q000378:metabolism*
D003603:Cytotoxins; D004852:Epoxy Compounds; D011506:Proteins; D020058:Styrene; C013690:styrene oxide; D019392:Cytochrome P-450 CYP2E1
Chem Res Toxicol. 2010 Jan;23(1):251-7
20020750
Int Arch Occup Environ Health. 1998 Feb;71(1):35-41
9523247
J Pharmacol Exp Ther. 1973 Oct;187(1):203-10
4147720
Drug Metab Rev. 2005;37(1):41-213
15747500
Arch Environ Health. 1968 May;16(5):656-62
5652389
Osaka City Med J. 1985 Aug;31(1):11-21
4094754
Crit Rev Toxicol. 1994;24 Suppl:S35-46
7818770
Biochem Biophys Res Commun. 1992 Feb 14;182(3):1348-55
1540179
J Pharmacol Exp Ther. 1973 Oct;187(1):195-202
4746327
Pharmacology. 1974;12(3):129-43
4445191
Fundam Appl Toxicol. 1997 Feb;35(2):152-65
9038236
Chem Res Toxicol. 1996 Mar;9(2):451-6
8839049
J Appl Toxicol. 1986 Dec;6(6):405-12
3805568
Scand J Work Environ Health. 1978;4 Suppl 2:254-8
734412
Carcinogenesis. 1983;4(1):1-3
6821880
Toxicology. 2006 Sep 21;226(2-3):99-106
16872732
Toxicol Appl Pharmacol. 1996 Nov;141(1):299-307
8917703
J Pharmacol Exp Ther. 2010 Mar;332(3):738-46
20008063
Chem Res Toxicol. 2007 Feb;20(2):316-21
17266334
Chem Biol Interact. 2009 Apr 15;179(1):38-44
18823962
Chem Biol Interact. 1995 Mar 30;95(1-2):79-87
7697755
Mutat Res. 1999 Sep 30;445(2):205-24
10575431
Am J Respir Cell Mol Biol. 1996 Jun;14(6):586-98
8652187
Scand J Work Environ Health. 1993 Aug;19(4):255-63
8235514
Proc Natl Acad Sci U S A. 1989 Jan;86(1):322-6
2911577
Cancer Detect Prev. 2003;27(4):275-84
12893075
BMC Chem Biol. 2009 Jun 12;9:5
19523227
Toxicol Sci. 2010 Jun;115(2):589-95
20176620
Adv Pharmacol. 1994;30:199-245
7833293
Environ Mol Mutagen. 1991;17(1):27-31
1991456
Bull Inst Marit Trop Med Gdynia. 1975;26(3-4):299-302
1203595
Chem Res Toxicol. 1992 May-Jun;5(3):406-10
1504264
Toxicology. 2008 Dec 5;254(1-2):1-10
18951947
Crit Rev Toxicol. 1989;19(3):227-49
2653733
Chem Res Toxicol. 1999 Sep;12(9):831-9
10490505
Mol Pharmacol. 1996 Sep;50(3):573-82
8794896
Proc Natl Acad Sci U S A. 1971 Jan;68(1):160-4
4395686
Toxicol Appl Pharmacol. 1973 Feb;24(2):279-97
4696311
Mutat Res. 1980 Dec;73(2):387-401
7464847
Toxicol Appl Pharmacol. 1997 Oct;146(2):317-27
9344900
Chem Res Toxicol. 1996 Oct-Nov;9(7):1159-66
8902272
Mutat Res. 2001 Oct 1;482(1-2):89-103
11535253
J Appl Toxicol. 2001 May-Jun;21(3):185-98
11404830
Toxicol Appl Pharmacol. 2000 Oct 1;168(1):36-49
11000098
Xenobiotica. 1997 Jan;27(1):101-10
9041682
Clin Chim Acta. 2006 Mar;365(1-2):9-29
16199025
Arch Toxicol Suppl. 1986;9:286-90
3468906
Annu Rev Pharmacol Toxicol. 1997;37:91-117
9131248
Toxicol Sci. 1998 Dec;46(2):266-81
10048130
Drug Metab Rev. 1993;25(4):395-451
8313837
Chem Res Toxicol. 1991 Mar-Apr;4(2):168-79
1664256